GSK Investigational Site
				
				Sacramento, California 95815
We've found
        5 trials
        at this facility
      	
	Anaemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	HIV INfections Clinical Trial
	
Updated: 12/31/1969
  
  
  Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neoplasms Clinical Trial
	
Updated: 12/31/1969
  
  
  Pilot Immunotherapy With Autologous T-cells Specific for New York Esophageal Antigen-1 (NY-ESO-1)/ Cancer-testis Antigen-2 (LAGE-1a)-Positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cholestasis Clinical Trial
	
Updated: 12/31/1969
  
  
  Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	
Updated: 12/31/1969
  
  
  A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	